New pill aims to tame deadly Stress-Induced heart condition
NCT ID NCT07263139
Summary
This study is testing a new oral drug called AGP100 for people with a serious inherited heart condition called CPVT. CPVT causes the heart to beat dangerously fast during physical or emotional stress, even with current medications. The trial will check if AGP100 is safe and if it helps patients maintain a normal heart rhythm while exercising. Ten participants will take three different doses of the drug over six weeks while continuing their usual heart medication.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Department of Cardiology, Oslo University Hospital
RECRUITINGOslo, Norway
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.